Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001048477-24-000112

EVP, Chief Legal Officer sold 40,850 shares at an average $74.51 ($3,043,802)

  • EVP, Chief Legal Officer acquired 40,850 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Davis George Eric · EVP, Chief Legal Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-28 Exercise or conversion : show line 1 in the form 10b5-1 +40,850 $63.10 $2,577,635 97,007 D
2024-05-28 Sale : show line 2 in the form 10b5-1 −38,071 $74.46 $2,834,576 58,936 D
2024-05-28 Sale : show line 3 in the form 10b5-1 −2,779 $75.29 $209,225 56,157 D
Open-market sales · 40,850 sh · avg $74.51 · $3,043,802

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-28 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy Common Stock) −40,850 0 D
Loading xslF345X05/wk-form4_1717107477.xml…